StreetInsider.com News Articles

Form EFFECT Freenome, Inc.

Fri, 28 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260828/26992634.html

Form EFFECT Freenome, Inc.

Fri, 28 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260828/26992634.html

Form 424B3 Freenome, Inc.

Thu, 27 Aug 2026 16:30:00 -0400

http://archive.fast-edgar.com/20260827/AK2PG62CZW22MZDA222L2Z42DBINZC22Z282

Filed on: August 27, 2026

Form 424B3 Freenome, Inc.

Thu, 27 Aug 2026 16:30:00 -0400

http://archive.fast-edgar.com/20260827/AK2PG62CZW22MZDA222L2Z42DBINZC22Z282

Filed on: August 27, 2026

Guggenheim Starts Freenome Inc. (FRNM) at Buy

Thu, 20 Aug 2026 06:19:40 -0400

Guggenheim analyst Subbu Nambi initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Freenome Inc. click here. For more ratings news on Freenome Inc. click here.

Shares of Freenome Inc. closed at $13.63 yesterday.

Form S-1 Freenome, Inc.

Tue, 18 Aug 2026 16:52:00 -0400

http://archive.fast-edgar.com/20260818/A82PM22CZW22BJK2222D2Z42IKGLZC22X282

Filed on: August 18, 2026

Form S-1 Freenome, Inc.

Tue, 18 Aug 2026 16:52:00 -0400

http://archive.fast-edgar.com/20260818/A82PM22CZW22BJK2222D2Z42IKGLZC22X282

Filed on: August 18, 2026

TD Cowen Starts Freenome Inc. (FRNM) at Buy

Tue, 18 Aug 2026 05:33:51 -0400

TD Cowen analyst Dan Brennan initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

The analyst comments "Recently public (via a SPAC) FRNM is anything but 'new' on the scene as the company is well known to investors given its first mover in liquid biopsy (LB) CRC screening. FRNM has differentiated LB chemistry, strong partnerships (ABT, Roche), & a roadmap in MCED and single cancer screening (lung first) that support a sales ramp from $107M in '26 ($7M ex milestone), $242M by '30 & ~$1B by '35."

For an analyst ratings summary and ratings

TD Cowen Starts Freenome Inc. (FRNM) at Buy

Tue, 18 Aug 2026 05:33:51 -0400

TD Cowen analyst Dan Brennan initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

For an analyst ratings summary and ratings

BTIG Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 05:31:31 -0400

BTIG analyst Mark Massaro initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

The analyst comments "We initiate coverage of Freenome with a Buy rating and $17 PT. We regard FRNM as a pioneer in blood-based ("liquid biopsy") testing and we believe FRNM is well positioned to become a leader in lung, colon, and multi-cancer early detection (MCED) screening for 10 cancer types. FRNM possesses a blood-based CRC screening test (SimpleScreen) that we think will be competitive to the Cologuard and Shield tests from Abbott (ABT, Buy, $134 PT; Analyst: Marie Thibault) and

BTIG Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 05:31:31 -0400

BTIG analyst Mark Massaro initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

BTIG Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 05:31:31 -0400

BTIG analyst Mark Massaro initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

BTIG Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 05:31:31 -0400

BTIG analyst Mark Massaro initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

Jefferies Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 02:30:51 -0400

Jefferies analyst Tycho Peterson initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

The analyst comments: “Freenome (FRNM) is developing a portfolio of blood-based cancer screening tests spanning CRC (120M eligible U.S. patients), lung (15M) and 10+ other indications. Leveraging proprietary multi-omics capabilities and partnerships with ABT (CRC only) and ROP-SW (ex-U.S. IVD), we see FRNM as uniquely positioned from a development and commercial standpoint, with a multi-year penetration ramp ahead.

Colorectal cancer screening (CRC) remains the near-term focus, following v1 FDA approval and recent release of v2 data, with a broader ABT-supported commercial

Jefferies Starts Freenome Inc. (FRNM) at Buy

Mon, 17 Aug 2026 02:30:51 -0400

Jefferies analyst Tycho Peterson initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Buy rating and a price target of $17.00.

Colorectal cancer screening (CRC) remains the near-term focus, following v1 FDA approval and recent release of v2 data, with a broader ABT-supported commercial

Form SCHEDULE 13G/A Freenome, Inc. Filed by: ADAR1 Capital Management, LLC

Fri, 14 Aug 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26932384.html

Form SCHEDULE 13G/A Freenome, Inc. Filed by: ADAR1 Capital Management, LLC

Fri, 14 Aug 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26932384.html

Form SCHEDULE 13G Freenome, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 12:36:00 -0400

si-local-file:///var/storage/secattach/20260814/26927922.html

Form SCHEDULE 13G Freenome, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 12:36:00 -0400

si-local-file:///var/storage/secattach/20260814/26927922.html

Leerink Starts Freenome Inc. (FRNM) at Outperform

Fri, 14 Aug 2026 06:12:10 -0400

Leerink analyst Puneet Souda initiates coverage on Freenome Inc. (NASDAQ: FRNM) with a Outperform rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Freenome Inc. click here. For more ratings news on Freenome Inc. click here.

Shares of Freenome Inc. closed at $11.61 yesterday.

Form 8-K/A Freenome, Inc. For: Jul 20

Thu, 13 Aug 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260813/26922887.html

Form 8-K/A Freenome, Inc. For: Jul 20

Thu, 13 Aug 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260813/26922887.html

Form SCHEDULE 13G/A Freenome, Inc. Filed by: IPConcept (Luxemburg) S.A.

Wed, 12 Aug 2026 17:34:00 -0400

si-local-file:///var/storage/secattach/20260812/26914466.html

Form SCHEDULE 13G/A Freenome, Inc. Filed by: IPConcept (Luxemburg) S.A.

Wed, 12 Aug 2026 17:34:00 -0400

si-local-file:///var/storage/secattach/20260812/26914466.html

Form SCHEDULE 13G/A Freenome, Inc. Filed by: 683 Capital Management, LLC

Wed, 12 Aug 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20260812/26910928.html